Alx Oncology Holdings (ALXO) Total Non-Current Liabilities (2019 - 2026)

Alx Oncology Holdings (ALXO) has 8 years of Total Non-Current Liabilities data on file, last reported at $23.5 million in Q1 2026.

• For the quarter ending Q1 2026, Total Non-Current Liabilities fell 12.98% year-over-year to $23.5 million; the trailing twelve-month figure through Mar 2026 stood at $23.5 million (down 12.98% YoY), and the FY2025 full-year result was $29.1 million, up 3.99% from the prior year.
• Total Non-Current Liabilities eased to $23.5 million in Q1 2026, from $29.1 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $48.2 million in Q2 2024 to a low of $15.3 million in Q1 2022.
• A 5-year average of $32.4 million and a median of $29.1 million in 2025 frame the typical range for Total Non-Current Liabilities.
• Across the five-year window, Total Non-Current Liabilities surged 146.58% in 2022 and slumped 46.4% in 2025, its largest moves.
• Tracing ALXO's Total Non-Current Liabilities over 5 years: stood at $37.7 million in 2022, then increased by 21.02% to $45.6 million in 2023, then sank by 38.72% to $28.0 million in 2024, then grew by 3.99% to $29.1 million in 2025, then slipped by 19.3% to $23.5 million in 2026.
• Business Quant data shows ALXO's Total Non-Current Liabilities at $23.5 million in Q1 2026, $29.1 million in Q4 2025, and $33.5 million in Q3 2025.